查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605765

連續皮下胰島素輸注市場，按產品類型、患者類型、最終用途、國家和地區 - 2024-2032年行業分析、市場規模、市場佔有率和預測

Continuous Subcutaneous Insulin Infusion Market, By Product Type, By Patient Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，持續皮下胰島素輸注市場規模為42.45億美元，2024年至2032年年複合成長率為9.89%。

連續皮下胰島素輸注市場-市場動態

人們對先進胰島素輸送設備的認知不斷增強，以推動市場需求

持續皮下胰島素輸注（CSII）市場受到糖尿病發病率上升和對先進胰島素輸送意識增強的推動，目前40%的1 型糖尿病患者使用胰島素幫浦。然而，高昂的醫療成本和有限的可及性可能會阻礙該行業的成長。相反，機會在於人工智慧和物聯網創新，這些創新可以增強泵浦功能和患者體驗，同時人工胰臟系統的進步有望擴大資料整合並改善血糖控制。

連續皮下胰島素輸注市場 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032年）每年將以 9.89%左右的年複合成長率成長

根據產品類型細分，系留幫浦預計將在2023年呈現最大市場佔有率

根據患者類型細分，1型是2023年的主導類型

依地區分類，北美是2023年的主要收入來源

連續皮下胰島素輸注市場-細分分析：

全球連續皮下胰島素輸注市場根據產品類型、患者類型、最終用途和地區進行細分。

市場依產品類型分為三類：貼片幫浦和繫留幫浦。系留泵領域主導市場。空氣對空氣熱泵幾乎不需要維護並且安裝簡單。選擇它而不是地源熱泵系統，因為沒有基礎工程成本且更具成本效益。

根據患者類型，市場分為兩類：1 型和 2 型。這主要是由於它的可存取性和攜帶性，佔據了重要的市場佔有率。這些設備可輕鬆佩戴在衣服內或外，為胰島素管理提供便利。

連續皮下胰島素輸注市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

連續皮下胰島素輸注市場-競爭格局：

全球市場的推動力是擴大採用先進的胰島素管理解決方案，強調方便用戶使用的技術和改進的血糖控制。市場策略包括加強設備與血糖監測系統整合的合作夥伴關係，為主動糖尿病管理提供即時資料和預測分析。此外，各公司正致力於開發緊湊、謹慎的胰島素幫浦和可客製化的劑量選項，以滿足特定患者的需求，特別是在管理不同人群的1 型糖尿病方面。

目錄

第1章 連續皮下胰島素輸注市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依產品類型分類的連續皮下胰島素輸注市場摘錄
    • 依患者類型分類的連續皮下胰島素輸注市場摘錄
    • 依最終用途分類的連續皮下胰島素輸注市場摘錄
    • 依國家分類的連續皮下胰島素輸注市場摘錄
    • 依地區分類的連續皮下胰島素輸注市場摘錄
  • 競爭洞察

第3章 持續皮下胰島素輸注主要市場趨勢

  • 連續皮下胰島素輸注市場促進因素
    • 市場促進因素的影響分析
  • 連續皮下胰島素輸注市場限制
    • 市場限制影響分析
  • 持續皮下胰島素輸注市場機會
  • 連續皮下胰島素輸注市場未來趨勢

第4章 連續皮下胰島素輸注產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 連續皮下胰島素輸注市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第6章 連續皮下胰島素輸注市場格局

  • 2023年連續皮下胰島素輸注市場佔有率分析
  • 依主要製造商分類的細分資料
    • 既有參與者分析
    • 新興參與者分析

第7章 連續皮下胰島素輸注市場 - 依產品類型

  • 概述
    • 依產品類型分類的細分市場佔有率分析
    • 貼片泵浦
      • 基礎和推注
      • 基礎
      • 推注
    • 繫留泵浦
      • 電池
      • 胰島素套件插入裝置
      • 胰島素儲存庫和藥筒

第8章 連續皮下胰島素輸注市場 - 依病患類型

  • 概述
    • 依患者類型分類的細分市場佔有率分析
    • 1型
    • 2型

第9章 連續皮下胰島素輸注市場 - 依最終用途

  • 概述
    • 依最終用途分類的細分市場佔有率分析
    • 實驗室
    • 居家護理
    • 醫院

第10章 連續皮下胰島素輸注市場 - 依地理位置

  • 介紹
    • 依地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美連續皮下胰島素輸注主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依產品類型）
    • 北美市場規模和預測（依患者類型）
    • 北美市場規模和預測（依最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲連續皮下胰島素輸注主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依產品類型）
    • 歐洲市場規模和預測（依患者類型）
    • 歐洲市場規模和預測（依最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區連續皮下胰島素輸注主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模和預測（依患者類型）
    • 亞太地區市場規模和預測（依最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲連續皮下胰島素輸注主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依產品類型）
    • 拉丁美洲市場規模與預測（依患者類型）
    • 拉丁美洲市場規模和預測（依最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲連續皮下胰島素輸注主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依產品類型）
    • 中東和非洲市場規模及預測（依患者類型）
    • 中東和非洲市場規模和預測（依最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA其他地區

第11章 主要供應商分析-連續皮下胰島素輸注產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Medtronic Inc.
    • CeQur
    • Tandem Diabetes Care
    • F Hoffmann-La Roche
    • Ypsomed
    • Insulet Corporation
    • Sooil Development
    • Valeritas Inc.
    • Cellenovo
    • B. Braun Melsungen AG
    • Bigfoot Biomedical, Inc.
    • Becton, Dickinson and Company
    • Fresenius SE & Co. KGaA
    • MicroPort Scientific Corporation
    • MannKind Corporation
    • Nipro Corporation
    • Shinmyung Mediyes CO., LTD.
    • Sanofi SA
    • Smiths Group PLC
    • Others

第12章 360 度分析師視角

第13章 附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4325

REPORT HIGHLIGHT

Continuous subcutaneous insulin infusion market size was valued at USD 4,245 Million in 2023, expanding at a CAGR of 9.89% from 2024 to 2032.

Continuous subcutaneous insulin infusion (CSII) is a diabetes management method that uses an insulin pump to deliver small, continuous doses of rapid-acting insulin under the skin. This method mimics the body's natural insulin release, which helps in maintaining stable blood glucose levels. Patients can adjust doses for meals or exercise, offering flexibility and better glycemic control. CSII is especially beneficial for individuals with type 1 diabetes who require precise insulin regulation throughout the day and night.

Continuous Subcutaneous Insulin Infusion Market- Market Dynamics

Growing awareness about advanced insulin delivery devices to propel market demand

The continuous subcutaneous insulin infusion (CSII) market is driven by rising diabetes rates and increased awareness of advanced insulin delivery, with 40% of type 1 diabetes patients currently using insulin pumps. However, high healthcare costs and limited accessibility may hamper the industry's growth. On the contrary, Opportunities lie in AI and IoT innovations that enhance pump functionality and patient experience, alongside the advancement of artificial pancreas systems which promise expanded data integration and improved glucose control.

Continuous Subcutaneous Insulin Infusion Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.89% over the forecast period (2024-2032)

Based on product type segmentation, tethered pump was predicted to show maximum market share in the year 2023

Based on patient type segmentation, type 1 was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Subcutaneous Insulin Infusion Market- Segmentation Analysis:

The Global Continuous Subcutaneous Insulin Infusion Market is segmented based on Product Type, Patient Type, End-use, and Region.

The market is divided into three categories based on product type: patch pumps and tethered pumps. The tethered pumps sector dominates the market. The air-to-air heat pump requires very little maintenance and is simple to install. It is chosen over ground source heat pump systems since there are no groundwork costs and it is more cost-effective.

The market is divided into two categories based on patient type: type 1 and type 2. The type 1 sector dominates the market and is likely to maintain its dominance during the forecast period. This is majorly due to its accessibility and portability, capturing a significant market share. These devices, easily worn under or outside clothing, offer convenience for insulin management.

Continuous Subcutaneous Insulin Infusion Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Continuous Subcutaneous Insulin Infusion Market- Competitive Landscape:

The global market is driven by the growing adoption of advanced insulin management solutions, emphasizing user-friendly technology and improved glycemic control. Market strategies include partnerships to enhance device integration with glucose monitoring systems, enabling real-time data and predictive analytics for proactive diabetes management. Additionally, companies are focusing on developing compact, discreet insulin pumps and customizable dosing options to cater to specific patient needs, particularly in managing type 1 diabetes across diverse demographics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic Inc.
  • CeQur
  • Tandem Diabetes Care
  • F Hoffmann-La Roche
  • Ypsomed
  • Insulet Corporation
  • Sooil Development
  • Valeritas Inc.
  • Cellenovo
  • B. Braun Melsungen AG
  • Bigfoot Biomedical, Inc.
  • Becton, Dickinson and Company
  • Fresenius SE & Co. KGaA
  • MicroPort Scientific Corporation
  • MannKind Corporation
  • Nipro Corporation
  • Shinmyung Mediyes CO., LTD.
  • Sanofi S.A.
  • Smiths Group PLC
  • Others

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Patch Pumps
  • Bolus
  • Basal
  • Basal & Bolus
  • Tethered Pumps
  • Battery
  • Insulin Set Insertion Devices
  • Insulin Reservoir & Cartridges

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1
  • Type 2

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Homecare
  • Hospitals

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Subcutaneous Insulin Infusion Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Subcutaneous Insulin Infusion Market Snippet by Product Type
    • 2.1.2. Continuous Subcutaneous Insulin Infusion Market Snippet by Patient Type
    • 2.1.3. Continuous Subcutaneous Insulin Infusion Market Snippet by End-use
    • 2.1.4. Continuous Subcutaneous Insulin Infusion Market Snippet by Country
    • 2.1.5. Continuous Subcutaneous Insulin Infusion Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Subcutaneous Insulin Infusion Key Market Trends

  • 3.1. Continuous Subcutaneous Insulin Infusion Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Subcutaneous Insulin Infusion Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Subcutaneous Insulin Infusion Market Opportunities
  • 3.4. Continuous Subcutaneous Insulin Infusion Market Future Trends

4. Continuous Subcutaneous Insulin Infusion Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Subcutaneous Insulin Infusion Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Continuous Subcutaneous Insulin Infusion Market Landscape

  • 6.1. Continuous Subcutaneous Insulin Infusion Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Subcutaneous Insulin Infusion Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Patch Pumps
      • 7.1.2.1. Basal & Bolus
      • 7.1.2.2. Basal
      • 7.1.2.3. Bolus
    • 7.1.3. Tethered Pumps
      • 7.1.3.1. Battery
      • 7.1.3.2. Insulin Set Insertion Devices
      • 7.1.3.3. Insulin Reservoir & Cartridges

8. Continuous Subcutaneous Insulin Infusion Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Type 1
    • 8.1.3. Type 2

9. Continuous Subcutaneous Insulin Infusion Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
    • 9.1.3. Homecare
    • 9.1.4. Hospitals

10. Continuous Subcutaneous Insulin Infusion Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Continuous Subcutaneous Insulin Infusion Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Medtronic Inc.
    • 11.2.2. CeQur
    • 11.2.3. Tandem Diabetes Care
    • 11.2.4. F Hoffmann-La Roche
    • 11.2.5. Ypsomed
    • 11.2.6. Insulet Corporation
    • 11.2.7. Sooil Development
    • 11.2.8. Valeritas Inc.
    • 11.2.9. Cellenovo
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Bigfoot Biomedical, Inc.
    • 11.2.12. Becton, Dickinson and Company
    • 11.2.13. Fresenius SE & Co. KGaA
    • 11.2.14. MicroPort Scientific Corporation
    • 11.2.15. MannKind Corporation
    • 11.2.16. Nipro Corporation
    • 11.2.17. Shinmyung Mediyes CO., LTD.
    • 11.2.18. Sanofi S.A.
    • 11.2.19. Smiths Group PLC
    • 11.2.20. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us